Objectives Lack of clarity on the definition of “patient engagement” has been highlighted as
a barrier to fully implementing patient engagement in research. This study identified themes …

Background There has been increasing evidence and debate on palliative care research
priorities and the international research agenda. To date, however, there is a lack of …

Concerns about rising spending on prescription drugs and other areas of health care have
led to multiple initiatives in the United States designed to measure and communicate the …

The systematic use of evidence to inform healthcare decisions, particularly health
technology assessment (HTA), has gained increased recognition. HTA has become a …

The rapid development of immuno-oncology (IO) therapies for multiple types of cancer has
transformed the cancer treatment landscape and brightened the long-term outlook for many …

The approach to patient engagement (PE) in drug development has changed rapidly due to
many factors, including the complexity of innovative drugs and the need to demonstrate …

A quote attributed to Mark Twain states,“What gets us into trouble is not what we don't know.
It's what we know for sure that just ain't so.” The growing focus on patient centricity has …

While evidence generated from health economic (HE) models is being used more commonly
in health technology assessment (HTA) in the US, it is not consistently adopted by different …

Background Acute hospital settings are generally not considered adequate places for end‐
of‐life care, but terminally ill patients will continue to die in acute medical wards in the …

Introduction Meaningful patient engagement (PE) can enhance medicines' development.
However, the current PE landscape is fragmentary and lacking comprehensive guidance …